Oxidative stress is a key mechanism in amyloid ␤-peptide (A␤)-mediated neurotoxicity; therefore, the protective roles of 17␤-estradiol (E 2 ) and antioxidants (Trolox and vitamin C) were assayed on hippocampal neurons. Our results show the following: 1) E 2 and Trolox attenuated the neurotoxicity mediated by A␤ and H 2 O 2 as measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide reduction assays, quantification of apoptotic cells, and morphological studies of the integrity of the neurite network. 2) Vitamin C failed to protect neurons from A␤ toxicity. 3) A␤-mediated endoperoxide production, reported to induce cell damage, was decreased in the presence of E 2 and Trolox. 4) Two key Wnt signaling components were affected by E 2 and Trolox; in fact, the enzyme glycogen synthase kinase 3␤ was inhibited by both E 2 and Trolox, and both compounds were able to stabilize cytoplasmic ␤-catenin. 5) E 2 activated the expression of the Wnt-5a and Wnt-7a ligands, and at the same time, E 2 , through the ␣-estrogen receptor, was able to prevent the excitotoxic A␤-induced rise in bulk-free Ca
Alzheimer disease (AD) 1 is a neurodegenerative disease characterized by neuronal cell death, dystrophic neurites, neurofibrillary tangles, and senile plaques (1) . Senile plaques are composed by the amyloid ␤-peptide (A␤), a 40 -42-amino acid peptide that originates from the proteolytic cleavage of the amyloid precursor protein (2) . There is also evidence relating the etiopathology of AD with oxidative stress induced by A␤ in the brain of AD patients (3) (4) (5) (6) . A␤ increases the production of intraneuronal reactive oxygen species (ROS) and stimulates hydrogen peroxide (H 2 O 2 ) levels through metal ion reduction (7, 8) . Free radicals peroxidize membrane lipids (9) and oxidize proteins (10) . In vitro experiments also support the observation that the neurotoxic effect of A␤ is mediated by free radical mechanisms (5, 11, 12) and alteration of Ca 2ϩ homeostasis (13) . Furthermore, several studies have reported neuroprotection by antioxidants against A␤-mediated cytotoxicity (14 -16) . Also, 17␤-estradiol (E 2 ; estrogen) treatment apparently has beneficial effects on AD (17, 18) . In addition, E 2 prevents A␤-induced cell death by activation of the ␣-ER (19) and preserves neuronal viability and function in cortical neurons exposed to glutamate toxicity (20) . Also, there is evidence that E 2 prevents morphological neurodegenerative changes in hippocampal neurons caused by A␤ deposits (21) .
On the other hand, neurofibrillary tangles are intracellular aggregates of paired helical filaments produced by hyperphosphorylation of the microtubule-associated protein tau (23) . It has been proposed that glycogen synthase kinase-3␤ (GSK-3␤) is a key enzyme in the hyperphosphorylation of tau protein (24) . Increased paired helical filaments were observed in transgenic mice overexpressing GSK-3␤ (25) . In addition, GSK-3␤ accumulates in the cytoplasm of pre-tangle neurons following the pathological progression of the disease (26) . In cortical and hippocampal neurons challenged with A␤, there is an activation of GSK-3␤ (24, 27) and tau hyperphosphorylation (23, 28) correlating with cell death (24, 28) . Besides, GSK-3␤ is involved in the signaling of insulin and insulin-like growth factor I (29) and also in wingless/Wnt signaling (30) . Wnt signaling is essential for development, synaptogenesis, and oncogenic processes (31) (32) (33) (34) (35) , and it has even been proposed to play a role in neurodegenerative disorders such as schizophrenia (36, 37) and AD (38, 39) . Wnt proteins inhibit GSK-3␤, disrupting a multiprotein complex comprising GSK-3␤ and its substrates in the Wnt signaling pathway, which, unlike other growth factors, do not require a priming phosphate (29) . Wnt signaling also inactivates GSK-3␤ via activation of the protein kinase C (PKC) enzyme (40, 41) , which is decreased in the cortex of AD patients * This work was supported by Fondo Nacional de Desarrollo Cientí-fico y Tecnológico Grant 3980024 and Field-Initiated Studies Program Grant 01-1029 (to F. J. M.) and Fondo de Areas Prioritarias Biomedicine Grant 13980001 (to N. C. I.) and by the Millennium Institute of Fundamental and Applied Biology. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
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In the present work, we have studied the neuroprotective properties of vitamin C, E 2 , and Trolox (a hydrosoluble analogue of vitamin E) on rat hippocampal neurons challenged with A␤ and H 2 O 2 . Incubation with E 2 and Trolox reduces the neuronal cell death induced by A␤ treatment, as evaluated by the MTT assay and the TUNEL assay for apoptosis. Both Trolox and E 2 decreased intraneuronal ROS levels. We also found that E 2 and Trolox can modulate the Wnt signaling pathway. In fact, both treatments decreased the level of the GSK-3␤ activity in neurons exposed to A␤. Moreover, such treatment increased ␤-catenin levels and regulated the expression of Wnt ligand genes. Moreover, treatment of hippocampal neurons with E 2 prevented the A␤-induced rise in the cytoplasmic calcium levels. Similar results were observed in the presence of conditioned medium enriched with the Wnt-7a ligand. Taken together, these results established that E 2 and Trolox protect neurons exposed to A␤. The mechanism involved is apparently related to modulation of the Wnt signaling pathway and regulation of the cytoplasmic calcium content of neuronal cells.
EXPERIMENTAL PROCEDURES
Materials-Synthetic A␤ 1-40 peptide corresponding to the human A␤ wild-type sequence was obtained from Chiron Corp. Inc. (Emeryville, CA) and Calbiochem. Chemicals (E 2 , Trolox, and vitamin C), culture media, and sera were obtained from Sigma, Roche Applied Science, Merck, and Invitrogen, and Fluo-3 AM was obtained from Molecular Probes (Leiden, The Netherlands). Propyl pyrazole triol (PPT) (␣-agonist of ER) and diarylpropionitrile (DPN) (␤-agonist of ER) were purchased from Tocris Cookson (Ellisville, MO), and ICI 182780 (antagonist of ER) was donated by Elger Entech (Jena, Germany).
Primary Rat Embryo Hippocampal Neuronal Cultures-Hippocampal neurons were isolated from 18-day-old Sprague-Dawley rat embryos. All experiments were carried out in accordance with the directives of the Council of the European Communities No. 86/609/CEE. Pregnant rats were killed by CO 2 inhalation. Then, embryos were rendered hypothermic and decapitated. Hippocampi were aseptically dissected and trypsinized for 20 min. After centrifugation for 1 min, cells were seeded in phenol red-free Dulbecco's modified Eagle's medium plus 10% horse serum into 1% poly-L-lysine-coated plates. After 120 min, medium was removed, and Neurobasal medium was added containing 1% B27 supplement from Invitrogen, plus streptomycin and penicillin. On day 3 of culture, hippocampal cells were treated with 2 M 1-␤-D-arabinofuranosylcytosine for 24 h to reduce the number of proliferating non-neuronal cells. Cultured hippocampal neurons were used for the experiments on day 6.
Aggregation of Amyloid ␤-Peptide-A␤ fibrils were obtained by dissolving freeze-dried aliquots of A␤ in Me 2 SO. Peptide stock aliquots were diluted in 0.1 M Tris-HCl (pH 7.4) to a final concentration of 100 M A␤. Solutions were stirred continuously (1300 rpm) at room temperature for 48 h. The quality of amyloid was verified by different criteria including turbidometry, Congo red binding, and thioflavine T spectrofluorometry (48, 49) . Aliquots of the homogenate were transferred to a denaturing buffer and resolved by Tris-glycine SDS-PAGE to quantify the concentration of A␤ contained in the fibrils. This was achieved by densitometric scanning using different A␤ concentrations as standard.
Cell Viability Assay (MTT Reduction)-MTT assays were performed as described previously (50, 51) . Hippocampal neurons (2 ϫ 10 4 cells/ 100 l/well) were assayed in B27-and phenol red-free medium. Neurons were pre-incubated for 2 h with 100 M vitamin C, 10 M E 2 , 100 M Trolox, or medium (control). Then, 5 M A␤ or 100 M H 2 O 2 was added to the wells. Cells were incubated for 24 h at 37°C, after which cell viability was measured by the MTT method. MTT reduction was determined in a Lab Systems Uniskam I spectrophotometer at 540 and 650 nm.
Immunofluorescence Studies-Hippocampal neurons were seeded onto poly-L-lysine-coated coverslips (20,000 neurons/cover) in 24-well culture plates. After 6 days in Neurobasal medium plus B27, neurons were washed and exposed to A␤ and antioxidants. Then, neurons were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100. Immunostaining was done with polyclonal anti-NF-200 antibody (1:300; Sigma). Antibody detection was made using rhodamine-conjugated anti-rabbit IgG antibody (Sigma). Coverslips were mounted and analyzed under a Zeiss confocal microscope. Neuronal morphology was analyzed by confocal microscopy, and the number and length of neurites were evaluated using Image-Pro Plus software (Media Cybernetic, Silver Spring, MD).
Neuronal Apoptosis by TUNEL Assay-Programmed cell death was evaluated by the TUNEL method using the In Situ POD Cell Death Detection Kit (Roche Applied Science). Hippocampal neurons were plated on poly-L-lysine-coated coverslips (50,000 neurons/cover). After 5 days in Neurobasal medium plus B27, hippocampal neurons were washed, starved for 2 h, and treated for 6 h. Then, neurons were fixed in fresh paraformaldehyde (4%) and permeabilized with 0.1% Triton X-100, and staining was performed as indicated by the manufacturer. Samples were analyzed under a light microscope (Olympus BX51TF), and the percentage of apoptotic cells (brown staining) on different fields was determined using the Image-Pro Plus program (Media Cybernetics), the data were subdivided into 10 intervals (from 0% to 100% apoptosis), and the frequency of each interval was calculated.
Measurement of Intracellular Free Radicals-Hippocampal neurons were incubated with the fluorochrome 2,7-dichlorofluorescein diacetate at 5 M for 2 h. Then, wells were washed three times with Hank's solution, and neurons were pretreated for 2 h with the corresponding antioxidants in phenol red-free Dulbecco's modified Eagle's medium. A␤ fibrils (5 M) were added to each well and incubated for 4 h. Cells were trypsinized, and fluorescence was monitored (excitation, 495 nm; emission, 520 nm) using a Shimadzu spectrofluorometer. Results are expressed as percentages relative to control neurons arbitrarily set at 100%.
GSK-3␤ Activity-After 5 days in Neurobasal medium plus B27, hippocampal neurons were treated for 6 h. Then, neurons were washed twice with cold Tris-buffered saline (50 mM Tris, 150 mM NaCl, pH 7.4) and lysed (25 mM HEPES, 125 mM NaCl, 25 mM NaF, 30 M Na 2 P 2 O 7 ⅐10H 2 O, 1 mM EDTA, 1% Nonidet P-40, 1 mM NaVO 3 , 100 g/ml phenylmethylsulfonyl fluoride, 2 g/ml aprotinin, 1 g/ml pepstatin, and 2 M leupeptin). To immunoprecipitate GSK-3␤, samples were incubated overnight with 10 l of rabbit polyclonal IgG anti-GSK-3␤ (Santa Cruz Biotechnology), and then 25 l of protein Aagarose (Santa Cruz Biotechnology) were added for 4 h. Immune complexes were centrifuged (425 ϫ g, 4°C, 1 min) and washed six times with cold immunoprecipitation buffer (25 mM HEPES, pH 7.4, 10 mM MgCl 2 , 1 mM NaF, 30 M Na 2 P 2 O 7 ⅐10H 2 O, 1 mM NaVO 3 , 100 g/ml phenylmethylsulfonyl fluoride, 2 g/ml aprotinin, 1 g/ml pepstatin, and 2 M leupeptin). Samples were resolved by 10% SDS-PAGE and transferred onto a nitrocellulose membrane. Then, membranes were incubated with goat anti-phosphotyrosine polyclonal IgG p-GSK-3␤ (Tyr-216) or goat polyclonal anti-phosphoserine p-GSK-3␤ (Ser-9) (Santa Cruz Biotechnology). Bands were revealed by the enhanced chemiluminescence method (Santa Cruz Biotechnology) using an antigoat horseradish peroxidase-conjugated secondary antibody. Films were scanned, and densitometry was carried out with MATRIX software (Quantavision).
The GSK-3␤ kinase activity assay was performed in immunoprecipitation buffer with 10 Ci of [␥-32 P]ATP and 62.5 M phospho-glycogen synthase peptide-2 (GS-2; Upstate Biotechnology) as substrate. After 30 min at 30°C, the reaction was analyzed by two different methods. 1) Samples were adsorbed to p81 phosphocellulose paper (Whatman, Pleasanton, CA) and washed three times for 15 min with 0.75% orthophosphoric acid, and then radioactivity was counted in a scintillation counter. 2) The reaction was stopped with protein charge buffer, and samples were resolved by Tris-glycine 16% SDS-PAGE; the gel was dried, and GSK-3␤ phosphorylation peptide substrate was assayed using autoradiography. Films were scanned, and densitometry was carried out with MATRIX software.
Cytoplasmic ␤-Catenin Stabilization-After 5 days in culture, hippocampal neurons were treated for 6 h in Neurobasal medium alone. Then, neurons were washed twice with cold phosphate-buffered saline and lysed (10 M HEPES, 1.5 M MgCl 2 , 10 M KCl, 1 M EDTA, 1 M dithiothreitol, 1 M phenylmethylsulfonyl fluoride, 1 g/l pepstatin, 1 g/ml aprotinin, and 10% glycerol) for 10 min at 4°C. Samples were centrifuged (4000 ϫ g, 4°C, 15 min), and supernatants were kept at 4°C to evaluate ␤-catenin. Samples were resolved by 10% SDS-PAGE and transferred onto a nitrocellulose membrane. Then, membranes were incubated with a mouse anti-␤-catenin antibody (Santa Cruz Biotechnology). Bands were revealed by the enhanced chemiluminescence method (Santa Cruz Biotechnology) using an anti-goat horseradish peroxidase-conjugated secondary antibody. Films were scanned, and densitometry was carried out as indicated above.
RNA Extraction and RT-PCR-After 6 days in Neurobasal medium plus B27, hippocampal neurons were kept in Neurobasal medium for 4 h. Then, cells were lysed with TRIzol reagent according to the manufacturer's instructions. RNA concentration was calculated by the absorbance measurement at 260 and 280 nm (UV-150 -02 Shimadzu spectrophotometer). In the RT-PCR assay, Moloney murine leukemia virus reverse transcriptase was used for the RT reaction. The PCR was performed with 2.5 l of RT reaction mixture (1 l of reaction buffer, 0.5 l of 10 mM deoxynucleotide triphosphate, 1.5 l of 25 mM MgCl 2 , 0.125 l of primers at 100 M, 1 l of Taq polymerase, and 16.75 l of diethyl pyrocarbonate-treated water). PCR conditions were as follows: for Wnt-5a, 1 min at 94°C, 1 min at 58°C, and 1 min at 72°C for 30 cycles; and for Wnt-7a, 1 min at 94°C, 1 min at 54°C, and 1 min at 72°C for 30 cycles. ␤-Actin was measured as a housekeeping gene, and its PCR amplification conditions were the same as those of the gene measured. RT-PCR primers for Wnt-5a, Wnt-7a, and ␤-actin were as follows: Wnt-5a, 5Ј-TGAACCTNCACAACAAYGAGGCGGG-3Ј (forward) and 5Ј-GAAGCGGCTGTTGACCTGTAC-3Ј (reverse); Wnt7a, 5Ј-TGAACCTN-CACAACAAYGAGGCGGG-3Ј (forward) and 5Ј-GCTTCTTGATCTTCA-GGAAGCGGCTGTTGACCTGTAC-3Ј (reverse); and ␤-actin, 5Ј-TCTA-CAATGAGCTGCGTGTG-3Ј (forward) and 5Ј-TACATGGCTGGGGTG-TTGAA-3Ј (reverse). PCR products were analyzed by electrophoresis on a 1% agarose gel poured in Tris acetic EDTA buffer. The band intensity for Wnt-5a and Wnt-7a was measured with MATRIX software, and normalized with ␤-actin band intensity.
Calcium Imaging and Fluorescence Measurements-Hippocampal neurons grown on glass coverslips were loaded for 30 min (37°C) with 5 M Fluo-3 in its AM form (Fluo-3 AM) in Krebs Ringer HEPESglucose containing 0.02% pluronic acid. Coverslips were washed three times and left in Krebs Ringer HEPES-glucose for 10 min until cell fluorescence reached a plateau. Fluorescence was imaged with a LSM Pascal Zeiss confocal microscope as described previously (52) . Background was measured in parts of the field devoid of neurons and found to be not significantly different from the signal recorded in neurons depleted of dye with 100 M digitonin. This value was subtracted from cell measurements. The fluorescence intensity variation was recorded from 20 -25 neurons on average per experiment. Estimation of fluorescence intensity of Fluo-3 AM was presented as the pseudoratio (⌬F/F) indicated by the following equation:
where F is the measured fluorescence intensity of the Ca 2ϩ indicator, F base is the fluorescence intensity before the stimulation, and B is the background signal determined from the average of areas adjacent to the neurons (52, 53) . Besides, from dye saturation, ⌬F/F is thought to approximately reflect [Ca 2ϩ ] if there is no change in dye concentration, intracellular environment, or path length (53) . Data are presented as the means Ϯ S.E. from four independent experiments with at least 20 -25 neurons per experiment.
Quantification of Copper-The Cu concentration was determined by means of a graphite furnace atomic adsorption spectrophotometer (SIMMA 6100; PerkinElmer Life Sciences). Calibration was performed against a standard curve prepared using dilutions of Cu standards, and the sample values were normalized to the total protein content (54) .
Statistical Analysis-Data were expressed as the means Ϯ S.E. of the values from the number of experiments indicated in the corresponding figures. Data were evaluated statistically by using Student's t test, with p Ͻ 0.05 considered significant. Analysis of variance was used to compare apoptosis distribution between different populations.
RESULTS

Trolox and E 2 Protect against A␤-mediated Toxicity in Rat Hippocampal Neurons
We evaluated the neuroprotective properties of three different antioxidant molecules: Trolox (a derivative of vitamin E), E 2 , and vitamin C. Hippocampal neurons challenged with A␤ were pretreated with Trolox, E 2 , or vitamin C (Fig. 1) . After 24 h, cell viability was measured by the MTT reduction assay (Fig. 1A) . As we expected, A␤ decreased cell viability (40%).
This effect was partially prevented by the presence of Trolox and E 2 (p Ͻ 0.05). However, vitamin C was unable to protect hippocampal neurons. This latter result is in contrast with reports that implicated vitamin C in the protection of neurons exposed to A␤ (55) . When neurons were exposed to H 2 O 2 , results similar to those observed with A␤ were obtained (Fig.  1B) . These results are in agreement with reports that implicated ROS generation in A␤-induced neuronal death (4, 7, 8) . In order to characterize the mechanism by which E 2 and Trolox protect against neuronal cell death, we evaluated apoptosis using the TUNEL assay. Fig. 2A illustrates a plot of apoptotic neurons (percentage of decrease) treated with A␤ in the presence of Trolox, E 2 , and vitamin C. Results indicate that the co-incubation of A␤ with E 2 or Trolox prevented the appearance of the apoptotic neuronal population; however, vitamin C was not able to prevent apoptosis. The effect was strong for Trolox (70%), but it was not as strong for E 2 (25%). These observations are consistent with the cell survival studies presented above. On the other hand, increased oxidative stress has been shown to contribute to the neurodegenerative process in AD (4, 5) . Indeed, A␤ has been shown to induce oxidative stress in many in vivo and in vitro models of AD (56) . The formation of intracellular free radicals in response to the action of A␤ was evaluated on hippocampal neurons (Fig. 2B ). Neurons treated with A␤ showed a high production of endogenous free radicals, and this effect was inhibited when cells were pretreated with Trolox (p Ͻ 0.005) or E 2 (p Ͻ 0.05). No effect was observed in neurons pretreated with 100 M vitamin C compared with those treated with only 5 M A␤. In this context, Shea and Ortiz (57) reported that E 2 reduces ROS levels in A␤-treated neuronal cultures. Our results suggests an antioxidant effect for Trolox and E 2 in A␤-treated hippocampal neurons.
Trolox and E 2 Maintain the Structural Integrity of Hippocampal Neurons Exposed to A␤
The loss of the neuronal connection and the neurite network is considered a marker of serious neuronal damage. A␤ triggers an extensive loss of neurites in different neuronal cells, and this effect can be prevented by treatment with lithium salts (39) and Wnt-3a conditioned medium (47) . Therefore, we evaluated the integrity of the neurite network in cells challenged with A␤ in the presence of Trolox, E 2 , and vitamin C by labeling the neurons with an anti-neurofilament antibody (Fig. 3) . Fig.  3A shows a graph that quantified the number of neurites/cell under different treatments. A␤ generates an extensive loss of neurites, preventing the normal connection between cells (Fig.  3C) , in relation to the control neurons (Fig. 3B ). This morphological pattern of neurodegeneration is correlated with the pattern of cell death obtained by both the MTT assay (Fig. 1A ) and the TUNEL assay ( Fig. 2A) . No major protective effect on neurites was observed when neurons were pretreated with vitamin C (Fig. 3D) . However, neurons pretreated with E 2 (Fig.  3E) or Trolox (Fig. 3F ) and challenged with A␤ showed an almost normal neurite network allowing interconnection among neurons. Pretreatments with Trolox and E 2 maintained the neurite network similar to that observed in the control neurons (data not shown). These results indicate that Trolox and E 2 prevent the neurodegenerative changes induced by A␤ treatment. In addition, in other models, E 2 -induced neuroprotection was correlated with the formation of a more dynamic microtubular system, an event that increases microtubule stability and prevents the neurite loss induced by A␤ (21) . Those results are consistent with the effects on A␤-treated hippocampal neurons observed here.
Trolox and E 2 Modulate Activation of the
Neuronal Wnt Signaling Pathway GSK-3␤ Activity-A loss of function of the Wnt signaling pathway has been found to play a role during ␤-amyloid neurotoxicity (35, 39, 47) , and key components of this pathway are affected in AD, i.e. ␤-catenin is reduced, and GSK-3␤ is activated in pre-neurofibrillary lesions (26, 45) . We decided to evaluate the changes observed in GSK-3␤ activity by following the phosphorylation of a GS-2 peptide substrate in vitro. The radioactive labeling on GS-2 peptide is considerably augmented in response to A␤ (Fig. 4A, a) . This correlates with the GSK-3␤ activity levels, immunodetected with an antibody that specifically indicated phosphorylation of the Tyr-216 residue, which represents the activation of GSK-3␤ (Fig. 4A, b ). This observation is followed with a decrease in the phosphorylation of the P-Ser-9 residue, detected by Western blot (Fig. 4A, c) . It is well established that Ser-9 phosphorylation down-regulates GSK-3␤ (22) . In fact, when neurons were pretreated with E 2 or Trolox, a significant decrease (p Ͻ 0.005) in the activity of GSK-3␤ was obtained (Fig. 4B) , and the incorporation of 32 P on GS-2 peptide decreases, as also occurs with P-Tyr-216 on GSK-3␤ (Fig. 4A, a and b) . However, the phosphorylation on P-Ser-9 increases (Fig. 4A, c) . These results established that the increase in GSK-3␤ activity induced by A␤ is completely prevented by coincubation with either Trolox or E 2 , indicating that both compounds interfere with the neurotoxic cascades triggered by A␤ on hippocampal neurons.
␤-Catenin Stabilization-Regulation of ␤-catenin stability is a crucial control point in Wnt signaling pathways (40) . GSK-3␤ induces the phosphorylation of ␤-catenin and triggers its degradation through the ubiquitin-proteasome pathway (44, 58) . Therefore, we investigated whether the protective effect of Trolox and E 2 in A␤-induced neurodegeneration was related to ␤-catenin stabilization. We found that A␤ decreases the levels of cytoplasmic ␤-catenin as described previously (39, 47) , and this change can be prevented by E 2 , Trolox, and vitamin C (Fig.  5) . Taken together, these results suggest that Trolox and E 2 can regulate the neuronal Wnt signaling pathway, modulating GSK-3␤ activity and stabilizing the cytoplasmic ␤-catenin levels. These parameters are the most representative hallmarks involved in regulation of the Wnt signaling pathway (35, 59, 60) .
Trolox and E 2 Modulate Expression of the Wnt Genes in Hippocampal Neurons
Because GSK-3␤ and ␤-catenin are involved in the Wnt signaling pathway and Trolox and E 2 modulated their activation, we decided to study the expression of Wnt ligand genes in response to these antioxidants (Fig. 6, A and B) . In RT-PCR experiments, we found that E 2 increases the expression of canonical and non-canonical Wnt ligands (35) , Wnt-7a and Wnt-5a (Fig. 6A, a and b) , as well as the Wnt target gene engrailed-1 (en-1) (Fig. 6A, c) mRNA levels. These increases in mRNA level are independent of the variations in the total amount of mRNA, as observed in Fig. 6B for the intraneuronal actin mRNA levels. Trolox treatment induces a modest increase in the Wnt-7a and Wnt-5A mRNA levels (Fig. 6B, a and  b) in comparison with the effect of E 2 . This is an interesting observation because the typical neuroprotective action of Trolox is via an antioxidant mechanism (61). Moreover, expression of en-1 (a target gene of the Wnt pathway) is required to prevent apoptosis in mesencephalic dopaminergic neurons, an event that supports the role of the Wnt pathway in neuroprotection (62) . These observations could be related to an alternative protective mechanism for neurons, in which both E 2 and Trolox can modulate Wnt ligand genes and Wnt target genes in hippocampal neurons exposed to A␤.
E 2 Reverts the Cytoplasmic Calcium Increase Produced by A␤ in Primary Hippocampal Neurons
It has been documented that E 2 mediates responses by genomic and non-genomic mechanisms, both of which are important for neuronal survival (63, 64) . There is evidence that at supraphysiological doses, E 2 acts through an antioxidant mechanism to prevent neuronal cell death (63) . More recently, in neurotoxicity studies, it has been shown that E 2 is able to protect ER-negative neuronal cell lines (64, 65) . However, there is also evidence showing E 2 neuroprotection in cells that express ERs. For instance, E 2 exposure attenuates toxicity in PC12 cells transfected with ␣-ER exposed to serum deprivation (66) . On the other hand, E 2 is neuroprotective against N-methyl-D-aspartate (NMDA)-and kainate-mediated neurotoxicity, an effect mediated by mitogen-activated protein kinase activation and stimulation of NMDA receptor phosphorylation (67) . This effect is concomitant with a severe decline in the cytoplasmic calcium levels induced by glutamate in cortical neurons (68) . We studied the cytoplasmic calcium changes in hippocampal neurons loaded with Fluo-3 AM. The intensity of the fluorescence changes is representative of the variations in the cytoplasmic calcium levels in hippocampal neurons (13, 53) . A␤ treatment produces an increased entry of calcium for 30 min, following regulation of calcium entry for 1 h (Fig. 7B, b) , as compared with control neurons (Fig. 7B, a) . The cytosolic calcium changes are illustrated in Fig. 7A , which shows the neuronal calcium levels in each condition, and representative confocal photographs of neurons labeled with Fluo-3 AM are presented. When we used E 2 at physiological concentrations (10 nM) in experiments on calcium homeostasis, E 2 treatment decreased calcium influx in A␤-treated neurons (Fig. 7A, c) . The specific ER blockade with 10 nM of antagonist ICI 182780 induced a similar A␤ bulk calcium cytoplasmic rise in neurons exposed to A␤ in the presence of E 2 (Fig. 7A, d) . This result suggests a role for ERs in the modulation of intracellular calcium perturbed by A␤. The activation of ERs with specific agonists for ␣-ER or ␤-ER shows different responses. PPT, an ␣-ER agonist, prevents the bulk rise in calcium produced by A␤ (Fig. 7A, e) . On the other hand, DPN, a ␤-ER agonist, does not protect against the rise in the cytoplasmic level of calcium in hippocampal neurons exposed to A␤ (Fig. 7A, f) . A summary plot in Fig. 7C shows the cytoplasmic calcium behavior observed in each condition and represents quantification of four independent experiments. Taken together, these observations support the role of ␣-ER in regulation of cytoplasmic calcium in A␤-treated neurons. Previous studies have demonstrated that E 2 treatment of hippocampal neurons attenuates the excytotoxic glutamate-induced rise in bulk-free cytoplasmic Ca 2ϩ , despite potentiation of the influx of Ca 2ϩ induced by glutamate (68). Besides, E 2 can regulate the ATP-induced Ca 2ϩ transients, an event that may be involved in nociceptive signaling in the peripheral nervous system (69) .
Effect of the Wnt Signaling Pathway on the Cytoplasmic Calcium Increase Induced by A␤
Previous studies from our laboratory suggest a significant role of the Wnt signaling pathway in protection from the neuronal cell death elicited by A␤ (39, 47) . Here, we evaluated whether the Wnt neuronal pathway is involved in modulation of the cytoplasmic calcium perturbations induced by A␤ ( 8). Therefore, we studied the cytosolic calcium changes in hippocampal neurons exposed to A␤ in the absence (Fig. 8A, b) or presence of the Wnt-7a ligand (Fig. 8A, d) . Results indicated that Wnt-7a, a ligand of the canonical Wnt pathway (35) , was very successful in protecting hippocampal neurons challenged with A␤ (Fig. 8A, d) . This observation is presented with the corresponding graph for each condition (Fig. 8A ) and the fluorescence photographs (Fig. 8B, b and d) that represent the intracellular calcium levels in each condition. The incubation with Wnt-7a ligand does not induce any disturbance in the cytoplasmic calcium level in relation with control neurons (Fig.  8A, a and c) . No effect was observed when Wnt-5a, a ligand of the non-canonical Wnt pathway, was studied (data not shown). This is surprising because some non-canonical pathways result in changes in cytoplasmic Ca 2ϩ levels (35) . These results suggest a novel role of the Wnt signaling pathway in the regulation of cytosolic calcium disturbances induced by A␤ treatment. Cytoplasmic calcium regulation may be involved in both neuronal protection against cellular death and the morphological neurite changes induced by A␤. These effects have been re- ported for both the Wnt neuronal pathway (39, 47) and the E 2 neuroprotection effect observed here. Therefore, our studies support the role of Wnt signaling and E 2 in the protection induced in A␤-treated neurons. DISCUSSION Oxidative stress has been implicated in the characteristic neurodegeneration found in AD (4 -6) . In the present work, we studied the neuroprotective effect of several molecules with antioxidant properties on the modulation of the Wnt signaling pathway and the cytosolic calcium increase induced by A␤. Nonetheless, the protective role of antioxidants shows some controversial reports. There are studies reporting no protection with vitamin E and Trolox against 25 M A␤ 1-42 and A␤ [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] in rat hippocampal cells (56, 70) and 50 M A␤ in PC12 cells (71) . The lack of protection in those studies may be due to the extremely high concentration of A␤ used. Contrary to this evidence, neuroprotection with vitamin E against the challenge to A␤ , A␤ , and A␤ [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] has been reported for PC12 cells (72) , neocortical synaptosomes (12) , and vascular cells (51) . These controversial results suggest that antioxidant protection involves several effects, which are not necessarily linked to a decrease in ROS levels. Our results show that E 2 and Trolox significantly attenuated the cell death induced by A␤ in hippocampal neurons. E 2 and Trolox protect against the neurodegenerative changes induced by A␤, including the neurite loss network and the pathological cytoplasmic calcium influx. Besides, Trolox and E 2 increase the expression of Wnt-7a and Wnt-5a ligand genes and the Wnt target gene en-1, indicating a novel role in modulation of the Wnt signaling pathway in hippocampal neurons. In fact, Trolox decreases the caspase-3 activity deregulated in A␤-treated neurons (data not shown). This observation indicates a role of antioxidants in several death effectors. However, an effect of Trolox on the cytoplasmic calcium dyshomeostasis induced by glutamate and H 2 O 2 was discarded in several reports (61) . Nevertheless, pretreatment with LiCl or Wnt-3a conditioned medium completely inhibited H 2 O 2 -induced mitochondrial collapse and DNA fragmentation in HEK-293 cells (74) . These results suggest that the Wnt signaling pathway can rescue neurons from H 2 O 2 -induced toxicity and that the protective action of Trolox in our system could be mediated by modulation of the ROS species and the Wnt signaling pathway. Antioxidants could act not only by eliminating the membrane damage elicited by free radicals (75) but also by inhibiting the intracellular damage triggered by A␤. Endoperoxides have been proposed to mediate A␤ toxicity in neuronal (11, 72) and vascular cells (51) . In relation to AD, the interaction among copper, amyloid precursor protein, and A␤ can result in ROS generation and subsequent oxidative stress (7, 8, 60) . Toxicity of A␤ in neuronal cultures was consistent with catalytic H 2 O 2 production increased by the presence of copper (8) . In fact, we actually checked the copper concentration in our hippocampal neuron culture (see Table I ). We found concentrations of copper in the range of 0.2-3 M in the different mediums used in our studies and the hippocampal culture process. Thus, it is probable that the neurodegenerative effects of A␤ may be mediated by the complexing of A␤ with copper. Besides, recent studies from Huang et al. (76) indicate that nucleation-driven aggregation of A␤ is dependent upon metal ions, such as copper and zinc, present at trace concentrations and that metal chelation attenuated the formation of soluble A␤ oligomers from a cell-free culture medium, an event that is involved in the toxicity mechanism of A␤ against hippocampal neurons. Moreover, evidence for apoptotic cell death induced by oxidative damage has been reported in AD brains (4) . Also, the severe decline in ROS levels in A␤-treated neurons observed with E 2 and Trolox treatment is in agreement with the results of previous studies by Shea and Ortiz (57) . Vitamin C (100 M) failed to inhibit A␤-mediated cytotoxicity. Similar results were obtained with A␤ [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] on rat hippocampal cells (70) . However, another study has reported neuroprotection by vitamin C, although at concentrations higher than those used in the present study (55) . The neuroprotective role of vitamin C is controversial due to its putative physiological role related to restoration of the antioxidant properties of vitamin E (77) . Besides, other authors have attributed prooxidant properties to vitamin C at high concentrations (78) , which are in agreement with our results using higher concentrations of vitamin C (data not shown). Additionally, vitamin C, 3,4-dihydroxyphenylalanine, and dopamine were excellent substrates for A␤-copper-mediated production of H 2 O 2 (8) . Vitamin C can modify its structure and becomes a powerful pro-oxidant molecule, inducing a neurotoxic effect in hippocampal neurons (8, 78) . Additionally, GSK-3␤ activity increased in HT22 neuronal cells exposed to glutamate and H 2 O 2 , suggesting that GSK-3␤ is involved in control of oxidative stress resistance in these cells (79) . However, in our studies, vitamin C was able to stabilize cytoplasmic ␤-catenin levels, an event involved in Wnt signaling activation. This effect can be explained by the activation of PKC mediated by vitamin C (80) . Modification of the regulatory domain of PKC by pro-oxidant agents stimulates cellular PKC activity (80) . Additionally, we reported that activation of PKC by phorbol 12-myristate 13-acetate drives the accumulation of cytoplasmic ␤-catenin and activates the transcriptional activation via ␤-catenin/T-cell factor/lymphoid enhancer factor-1 of Wnt target genes (41) . Besides, vitamin C can increase the expression of developmental genes in neuronal cells and does not induce any changes in neuronal cell death protection genes (81) . Additionally, Western blot and immunohistochemistry for ␤-catenin in brain cortex, brain stem, and cerebellum revealed differential accumulation of this protein in different types of brain cells including neurons, astrocytes, and oligodendrocytes at different developmental stages (82) . E 2 has been reported as a neuroprotective agent against A␤ , A␤ , and A␤ [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] in assays at 4 -48 h on HT22 cells (11) , hippocampal cells (14) , and PC12 and Neuro-2a cells (15, 83) . The antioxidant property of E 2 (63) is independent of its classical mechanisms of action (17) . In addition to its antioxidant activity, other biological actions such as a decrease in A␤ release (84, 85) , an enhancement of amyloid aggregate uptake by microglial cells (86) , an increase in the synthesis of cholineacetyltransferase (87) , and the promotion of neuronal growth (88) have been described, making estrogens useful tools for the design of future therapeutic strategies in AD. Additionally, there is evidence showing E 2 neuroprotection in cells that express estrogen receptors. In addition, in an in vivo model of ischemia, ␣-ER was found to be critical to protect against brain injury (89) . The role of ␤-ER in mediating neuroprotection is more controversial. ␤-ER was not sufficient to protect against ischemia (89) . Besides, E 2 does not induce protection against ␤-amyloid toxicity in HT22 cells stably transfected with ␤-ER. The effects of E 2 on neuronal morphology and cytoplasmic calcium regulation have been reported previously (21, 57) . These studies demonstrated that E 2 treatment of hippocampal neurons attenuates the excitotoxic glutamate-induced rise in bulk-free cytoplasmic Ca 2ϩ (68) . Additionally, E 2 preserved both neuronal viability and function in an in vitro glutamate toxicity model (20) . In addition, E 2 can regulate activation of the NMDA receptors by the mitogen-activated protein kinase pathway, an event that is involved in the long terminal potentials neuronal response (67) . In our system, E 2 was able to prevent the cytosolic calcium induced by A␤. This effect seems to be regulated by activation of ␣-ERs, without participation of ␤-ERs. These results are in agreement with above-mentioned reports that relate the E 2 neuroprotection mechanism with the activation of ␣-ERs in neurons exposed to A␤ and glutamate. However, because E 2 can regulate NMDA receptor activation, we cannot exclude the possibility that E 2 can decrease the rise in cytosolic calcium induced by A␤ by this pathway. Thus, the role of ␣-ERs in the regulation of cytosolic neuronal calcium is a novel contribution of this study and can explain the different actions of E 2 in the neuroprotection mechanism.
A recent report from Cardona-Gómez et al. (90) showed that in vivo, E 2 induces a transient activation of GSK-3␤ in the adult female rat hippocampus, followed by a more sustained inhibition, as inferred from the tau phosphorylation levels. In addition, these results showed a novel complex that includes ␣-ER, GSK-3␤, and ␤-catenin. Considering the role of GSK-3␤ in neurodegeneration, our data suggest that part of the neuroprotective effects of E 2 may be due to the control of GSK-3␤ and to the formation of the ␣-ER, GSK-3␤, and ␤-catenin complex in A␤-treated neurons. These observations are consistent with a potential role of E 2 in modulation of the Wnt signaling pathway in neurons challenged with A␤. A scheme showing the main effects promoted by A␤ and the contribution of Trolox and E 2 for the neuronal viability is depicted in Fig. 9 .
An interesting observation of the present study relates to the finding that hippocampal cultures exposed to either A␤ or H 2 O 2 lose their neurite network, a hallmark of early neuronal damage. In fact, the initial steps of AD dementia are associated with the loss of neuronal connections and the appearance of dystrophic neurites (91) . Our results show that Trolox and E 2 significantly attenuated loss of the neurite network and its functional activity when hippocampal neurons were exposed to A␤ and H 2 O 2 . Moreover, it has been reported that neurons challenged by A␤ have an increase in the activity of GSK-3␤ related with the hyperphosphorylation of tau protein and the loss of the microtubular network (24) , and more recently, the inhibition of GSK-3␤ by E 2 has been demonstrated in rat hippocampus (90) . In the present work, we found that E 2 and Trolox significantly inhibit GSK-3␤ activity in neurons exposed to A␤. The mechanisms mediating this effect could involve the classical intracellular pathways directed to neuroprotection such as activation of PKC, phosphatidylinositol 3-kinase/AKT, or extracellular signal-regulated kinase signaling, however, further work is needed to address the specific mechanism involved in the activation of GSK-3␤ by A␤ and the inhibition of the enzyme by E 2 and Trolox. Additionally, it has been shown that GSK-3␤ activation is involved in growing axons and cones and in the regulation of microtubule and actin filament stability (92) . In this context, our studies complement the work of Shah et al. (21) , which showed that E 2 -induced neuroprotection increases microtubule stability and prevents the neurite loss induced by the A␤ peptide. In addition, the activation of axin (a scaffold protein involved in the Wnt pathway) through dishevelled stabilizes the neuronal microtubule network, resulting in local changes in the length of the neurites and in the increase of the axonal area (93) . Therefore, we think there is strong evidence to support the involvement of Wnt signaling pathway activation in control of the microtubule network. In our studies, Trolox and E 2 are capable of producing this modification, probably by modulating the Wnt signaling pathway. Trolox and E 2 induce the expression of Wnt-5a and Wnt-7 ligand genes. These findings could be related to an alternative mechanism of protection from neuronal cell death by Trolox and E 2 . Additionally, there are other mechanisms involved in E 2 -induced neuropro-tection in A␤-treated neurons. Previous findings in our laboratory indicate that the anti-apoptotic gene bcl-2 is regulated by Wnt signaling (60); in fact, lithium, a compound that mimics Wnt signaling activation (94) , and Wnt-3a ligand cause a timedependent increase in bcl-2 mRNA levels in primary rat hippocampal neurons (60) . Also, the ␤-catenin analogue plakoglobin induces bcl-2 expression (95) . Previous findings have demonstrated that A␤ decreases neuronal bcl-2 protein levels in vitro (96) and that bcl-2 immunoreactivity is reduced in tangle-bearing neurons of AD patients (97) . Our results indicate that antioxidants increase the production of Wnt ligand mRNA, and by doing this, they could activate the Wnt/␤-catenin/bcl-2 cascade that induces neuroprotection because there is evidence that antioxidants also promote bcl-2 expression (68).
Preclinical trials and epidemiological studies suggest that several agents may help prevent the development of AD or slow down disease deterioration. The preclinical evidence supporting the use of antioxidants to prevent or slow down AD is interesting. Our results correlate with epidemiological studies reporting a delay in the onset of AD in patients who have been treated with E 2 or antioxidants (17, 98 -100) , although there is still controversy about the epidemiological studies (101) . Moreover, clinical and experimental data suggest that E 2 may play a role in the genesis and perpetuation of colorectal cancer (102) . The mechanism by which E 2 exerts proliferative properties has been assumed to be exclusively mediated by genomic actions. Interestingly, E 2 induced a rapid cellular alkalinization of crypts and cancer cells that was sensitive to Na/H exchanger blockade or PKC inhibition (103) . Recent postmenopausal E 2 therapy has been associated with improved cognitive functioning, a reduced risk of dementia in women with Parkinson disease, and decreased risk of AD (103) . Additionally, in epithelial cells of the choroid plexus, AD patients had lower ␣-ER densities compared with non-AD patients (73, 103) . In other studies, it was determined that a steroidal formulation of nine synthetic conjugated E 2 derived from soybean and yam extracts exerted neurotrophic and neuroprotective effects in cultured neurons (73) . Indices of neuroprotection included an increase in neuronal survival, a decrease in neurotoxin-induced lactate dehydrogenase release, a reduction in neurotoxin-induced apoptotic cell death, and an attenuated glutamate-induced [Ca 2ϩ ] i rise. The novel finding presented in this study provides alternative mechanisms for some of the actions of E 2 and Trolox in neuroprotection. These represent effects on neuronal calcium and regulation of cytoskeletal and growth-associated genes related to the Wnt signaling pathway. FIG. 9 . Trolox and 17␤-estradiol protect against the A␤ toxicity modulating the Wnt pathway, ROS, and calcium levels. The oxidative stress generated by A␤ can be modulated with antioxidant molecules; the damage includes lipid peroxidation (1) or involves the A␤-mediated activation of receptor (2) . The role of the Wnt neuronal pathway in neurodegeneration induced by A␤ has been reported previously (39) , and specific activation with ligands (Wnt-3a and Wnt7a) can prevent the viability and extensive neurite network loss induced by amyloidogenic stress (3) . The E 2 neuronal protection mechanism involved control of the cytoplasmic calcium levels elevated by A␤ (4). This effect can be mediated by inhibition of calcium-specific receptors or activation of ␣-ER (5).
